Hrytsenko, Yana
Shea, Benjamin
Elgart, Michael
Kurniansyah, Nuzulul
Lyons, Genevieve
Morrison, Alanna C.
Carson, April P.
Haring, Bernhard
Mitchell, Braxton D.
Psaty, Bruce M.
Jaeger, Byron C.
Gu, C. Charles
Kooperberg, Charles
Levy, Daniel
Lloyd-Jones, Donald
Choi, Eunhee
Brody, Jennifer A.
Smith, Jennifer A.
Rotter, Jerome I.
Moll, Matthew
Fornage, Myriam
Simon, Noah
Castaldi, Peter
Casanova, Ramon
Chung, Ren-Hua
Kaplan, Robert
Loos, Ruth J. F.
Kardia, Sharon L. R.
Rich, Stephen S.
Redline, Susan
Kelly, Tanika
O’Connor, Timothy
Zhao, Wei
Kim, Wonji
Guo, Xiuqing
Ida Chen, Yii-Der
,
Sofer, Tamar
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL161012)
Article History
Received: 22 January 2024
Accepted: 22 May 2024
First Online: 30 May 2024
Competing interests
: B Psaty serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. G Lyons is currently a full time employee of Alexion, AstraZeneca Rare Disease, and hold stock in the company, however, her contributions to the present manuscript were performed as part of her previous affiliation at the Harvard T.H. Chan School of Public Health and this work is not related to her current occupation and affiliation. M Moll has received grant funding from Bayer and consulting fees from TriNetX, 2ndMD, TheaHealth, Sitka, Verona Pharma, and Axon Advisors. All other authors report no competing interests.